VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $398,000 | +25.9% | 17,149 | -13.5% | 0.01% | +25.0% |
| Q1 2018 | $316,000 | -30.7% | 19,822 | -9.8% | 0.00% | -33.3% |
| Q4 2017 | $456,000 | +13.7% | 21,986 | -21.4% | 0.01% | 0.0% |
| Q3 2017 | $401,000 | -17.7% | 27,971 | -0.5% | 0.01% | -33.3% |
| Q2 2017 | $487,000 | +8.9% | 28,111 | -30.9% | 0.01% | 0.0% |
| Q1 2017 | $447,000 | +11.5% | 40,653 | +46.8% | 0.01% | 0.0% |
| Q4 2016 | $401,000 | -52.2% | 27,700 | -19.0% | 0.01% | -55.0% |
| Q3 2016 | $839,000 | +30.1% | 34,183 | +6.3% | 0.02% | +17.6% |
| Q2 2016 | $645,000 | – | 32,144 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |